LPL Financial LLC Sells 275 Shares of Cooper Companies Inc (NYSE:COO)

LPL Financial LLC decreased its holdings in shares of Cooper Companies Inc (NYSE:COO) by 6.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,965 shares of the medical device company’s stock after selling 275 shares during the period. LPL Financial LLC’s holdings in Cooper Companies were worth $1,336,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Flagship Harbor Advisors LLC raised its stake in Cooper Companies by 62.5% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock worth $26,000 after buying an additional 30 shares during the period. Evolution Wealth Advisors LLC acquired a new position in Cooper Companies during the 2nd quarter worth approximately $34,000. Whittier Trust Co. acquired a new position in Cooper Companies during the 2nd quarter worth approximately $53,000. Ibex Wealth Advisors acquired a new position in Cooper Companies during the 2nd quarter worth approximately $52,000. Finally, Zions Bancorporation N.A. acquired a new position in Cooper Companies during the 1st quarter worth approximately $53,000. Institutional investors own 95.71% of the company’s stock.

In other Cooper Companies news, Director Jody S. Lindell sold 3,000 shares of the stock in a transaction on Monday, June 24th. The stock was sold at an average price of $328.29, for a total transaction of $984,870.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Allan E. Rubenstein sold 1,335 shares of the stock in a transaction on Wednesday, September 11th. The shares were sold at an average price of $299.61, for a total value of $399,979.35. Following the transaction, the director now directly owns 3,591 shares of the company’s stock, valued at $1,075,899.51. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.



A number of research firms recently weighed in on COO. Raymond James reaffirmed a “buy” rating on shares of Cooper Companies in a research note on Monday, August 26th. Northcoast Research reaffirmed a “buy” rating and set a $340.00 price target (up from $331.00) on shares of Cooper Companies in a research note on Monday, June 3rd. KeyCorp set a $351.00 price target on Cooper Companies and gave the stock a “buy” rating in a research note on Friday, August 30th. Wells Fargo & Co upped their price target on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Finally, Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price target on the stock in a research note on Friday, June 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $326.27.

Shares of COO traded down $0.15 on Thursday, reaching $302.95. 40,436 shares of the company’s stock traded hands, compared to its average volume of 357,879. The company has a current ratio of 1.29, a quick ratio of 0.73 and a debt-to-equity ratio of 0.39. The stock has a market cap of $15.00 billion, a PE ratio of 26.34, a PEG ratio of 2.29 and a beta of 0.93. The stock’s 50 day simple moving average is $321.32 and its two-hundred day simple moving average is $309.38. Cooper Companies Inc has a 52-week low of $228.65 and a 52-week high of $344.32.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, August 29th. The medical device company reported $3.23 EPS for the quarter, beating the Zacks’ consensus estimate of $3.16 by $0.07. The company had revenue of $679.40 million during the quarter, compared to the consensus estimate of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. Cooper Companies’s revenue was up 2.9% on a year-over-year basis. During the same period last year, the business posted $3.00 earnings per share. Analysts forecast that Cooper Companies Inc will post 12.32 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: What are the advantages to having securities held in street name?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.